About us

Innovative platforms

Therapeutic areas

Services

Resources

Pole NSL: ImaBiotech signe avec Bruker un partenariat international pour Quantinetix

In-the-press-Imabiotech

Pole NSL: ImaBiotech signe avec Bruker un partenariat international pour Quantinetix

Download (French version only)

Request a quote

I accept to receive the newsletter

Recent news

GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions
Newsletter September 2021
Webinar: Leveraging the Unique Combination of Bioanalysis and Spatial Bioanalysis to Accelerate Drug Development
Spatial Quantification of Biomarkers within Target tissues with Image analysis platform
Fluidigm announces collaboration agreement with Imaging CRO ImaBiotech to increase biopharma access to Imaging Mass Cytometry

Categories

Application notes
Articles and research
CNS
Conferences and Webinars
Dermatology
Imabiotech news
Mass Spectrometry Imaging
Oncology
Ophthalmology
Press releases & In the Press

Search news

© ImaBiotech 2018-2019

Build Your Pathway

First Name *

Last Name *

Company

Email *

Molecule

Target

Pathway

Phenotype

Area

If your request is not listed above, please specify it here